HOMER1 and Alzheimer disease: Its expression is increased in reactive astrocytes in AD patients and 8 month and older APP/PS1 mice, and colocalization analysis of Homer and synaptophysin showed that chronic treatment with a P2Y1R antagonist prevented the decrease in synaptic density that is normally observed in these mice (Reichenbach et al., 2018).